Adverse drug events and the associated factors in patients with chronic Chagas disease

被引:1
作者
da Cunha Lopes, Luiza Braz [1 ]
Pereira, Raquel Rodrigues [1 ]
Andrade, Patricia Mello [1 ]
Carneiro, Fernanda Martins [1 ]
Felix Mediano, Mauro Felippe [1 ]
Linnemann Kilgore, Sophia Isabel [1 ]
Hasslocher-Moreno, Alejandro Marcel [1 ]
de Sousa, Andrea Silvestre [1 ]
Evangelista Oliveira, Manoel Marques [2 ]
Saraiva, Roberto Magalhaes [1 ]
de Holanda, Marcelo Teixeira [1 ]
Sperandio da Silva, Gilberto Marcelo [1 ]
机构
[1] Fundacao Oswaldo Cruz, Inst Nacl Infectol Evandro Chagas, Rio De Janeiro, RJ, Brazil
[2] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil
关键词
Chagas disease; Adverse drug event; Cardiomyopathy; SAFETY;
D O I
10.1590/0037-8682-0443-2019
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Introduction: Herein, we aimed to identify the factors associated with adverse drug events (ADEs) in chronic Chagas disease (CD) patients. Methods: We analyzed 320 medical notes from 295 patients. The Naranjo algorithm was applied to determine the cause of ADEs. Mixed effects logistic regression was performed to evaluate the factors associated with ADEs. Results: ADEs were described in 102 medical notes (31.9%). Captopril was most frequently associated with ADEs. Age (RR 0.96; 95%CI 0.94-0.99) and cardiac C/D stages (RR 3.24; 95%CI 1.30-4.58) were the most important clinical factors associated with ADEs. Conclusions: Close follow-up is warranted for CD patients.
引用
收藏
页数:5
相关论文
共 15 条
  • [1] Pharmacological treatment of chronic heart failure
    Adorisio, Rachele
    De Luca, Leonardo
    Rossi, Joseph
    Gheorghiade, Mihai
    [J]. HEART FAILURE REVIEWS, 2006, 11 (02) : 109 - 123
  • [2] A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy
    Botoni, Fernando A.
    Poole-Wilson, Philip A.
    Ribeiro, Antonio L. P.
    Okonko, Darlington O.
    Oliveira, Brilullo M. R.
    Pinto, Airandes S.
    Teixeira, Mauro M.
    Teixeira, Antonio L., Jr.
    Reis, Adelina M.
    Dantas, Jackellyne B. P.
    Ferreira, Cid. S.
    Tavares, Wilson C., Jr.
    [J]. AMERICAN HEART JOURNAL, 2007, 153 (04) : 544.e1 - 544.e8
  • [3] Impact of pharmaceutical care on the quality of life of patients with heart failure due to chronic Chagas disease: Randomized clinical trial
    Chambela, Mayara da Costa
    Felix Mediano, Mauro Felippe
    Carneiro, Fernanda Martins
    Ferreira, Roberto Rodrigues
    Waghabi, Mariana Caldas
    Mendes, Veronica Goncalves
    Oliveira, Luciano de Souza
    de Holanda, Marcelo Teixeira
    de Sousa, Andrea Silvestre
    da Costa, Andrea Rodrigues
    Xavier, Sergio Salles
    Sperandio da Silva, Gilberto Marcelo
    Saraiva, Roberto Magalhaes
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (01) : 143 - 154
  • [4] Adverse drug reactions in special populations - the elderly
    Davies, E. A.
    O'Mahony, M. S.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 80 (04) : 796 - 807
  • [5] Pharmacologic therapy of chronic heart failure
    Hamad, Eman
    Mather, Paul J.
    Srinivasan, Siva
    Rubin, Sharon
    Whellan, David J.
    Feldman, Arthur M.
    [J]. AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2007, 7 (04) : 235 - 248
  • [6] Safety of benznidazole use in the treatment of chronic Chagas' disease
    Hasslocher-Moreno, Alejandro M.
    do Brasil, Pedro E. A. A.
    de Sousa, Andrea S.
    Xavier, Sergio S.
    Chambela, Mayara C.
    Sperandio da Silva, Gilberto M.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (05) : 1261 - 1266
  • [7] Prevalence and factors associated with polypharmacy in the older people: 2006-2014
    Manuel Carmona-Torres, Juan
    Isabel Cobo-Cuenca, Ana
    Recio-Andrade, Beatriz
    Alberto Laredo-Aguilera, Jose
    Martins, Maria Manuela
    Aurora Rodriguez-Borrego, Maria
    [J]. JOURNAL OF CLINICAL NURSING, 2018, 27 (15-16) : 2942 - 2952
  • [8] A METHOD FOR ESTIMATING THE PROBABILITY OF ADVERSE DRUG-REACTIONS
    NARANJO, CA
    BUSTO, U
    SELLERS, EM
    SANDOR, P
    RUIZ, I
    ROBERTS, EA
    JANECEK, E
    DOMECQ, C
    GREENBLATT, DJ
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 30 (02) : 239 - 245
  • [9] Dias JCP, 2016, EPIDEMIOL SERV SAUDE, V25, P7, DOI [10.5123/S1679-49742016000500002, 10.5123/s1679-49742016000500002]
  • [10] Chagas disease
    Rassi, Anis, Jr.
    Rassi, Anis
    Marin-Neto, Jose Antonio
    [J]. LANCET, 2010, 375 (9723) : 1388 - 1402